SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

DERM

Journey Medical Corp
NASDAQHealth Care

Latest close: 4.97 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 12, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 12, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jun 26, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record21010 flagged findings
Reported transactions (Form 4)47since Jul 8, 2024 · and 4 other holdings
Corporate events (8-K)23since Nov 12, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-12share offering or dilution eventfreshOpen filing ↗
    “…had working capital of $ 27.0 million as compared to $ 29.4 million at December 31, 2025. The Company relies primarily on cash on…”
    +1 more passage from the same document
    • “…31, 2025, and working capital of $27.0 million at June 30, 2026, compared to $29.4 million of working capital at December 31, 2025.…”
  • 2026-05-13share offering or dilution eventrecentOpen filing ↗
    “…had working capital of $ 27.1 million as compared to $ 29.4 million at December 31, 2025. The Company relies primarily on cash on…”
    +1 more passage from the same document
    • “…at December 31, 2025, and working capital of $27.1 million at March 31, 2026, compared to $29.4 million at December 31, 2025.…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 210)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 26SCHEDULE 13G/A ↗Passive stake · Wasatch Advisors LP · 11.0% · event on Sep 30, 26 · amendment
  • Aug 12, 2610-Q ↗Quarterly report
  • Aug 12, 268-K ↗Current report · Results
  • Jul 31, 26SCHEDULE 13G/A ↗Passive stake · Vanguard Capital Management · 3.6% · event on Jun 30, 26 · amendment
  • Jul 15, 26SCHEDULE 13G/A ↗Passive stake · Wasatch Advisors LP · 13.3% · event on Jun 30, 26 · amendment
  • Insider transaction · 8 Form 4 filingsshow all 8hide
  • Jun 26, 268-K ↗Current report · Shareholder vote results
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results
  • Apr 30, 26SCHEDULE 13G ↗Passive stake · Vanguard Capital Management · 5.7% · event on Mar 31, 26
  • Apr 30, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 30, 26DEF 14A ↗Shareholder meeting and votes
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Apr 21, 268-K ↗Current report · Other events
  • Apr 6, 26SCHEDULE 13G/A ↗Passive stake · Wasatch Advisors LP · 10.0% · event on Mar 31, 26 · amendment
  • Mar 26, 2610-K ↗Annual report

210 filings on record, the oldest from Aug 20, 21.

Listing the 25 most recent filings of the 210 on record.

8-Ks, explained

Stress1Structure13Governance9
  • Sep 26, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Aug 28, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 3, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 12, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 25, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 1, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 2, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Dec 8, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 6, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 18, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 23, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 22, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

5 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Wasatch Advisors LP11.0%Sep 30, 26SCHEDULE 13G/A ↗4 earlier filings
  • TANG CAPITAL MANAGEMENT, LLC8.0%Mar 31, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
  • Vanguard Capital Management3.6%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • May 2, 25Sell$20KRamsey AlloushCOO↗
  • May 2, 25Sell$16KJoseph BeneschCFO↗
  • May 2, 25Sell$33KClaude MaraouiPresident & CEO↗
  • Mar 11, 25Sell$247KClaude MaraouiPresident & CEO↗
  • Mar 7, 25Sell$75KClaude MaraouiPresident & CEO↗
  • Mar 6, 25Sell$129KClaude MaraouiPresident & CEO↗
  • Mar 5, 25Sell$93KClaude MaraouiPresident & CEO↗
  • Mar 4, 25Sell$146KClaude MaraouiPresident & CEO↗
  • Mar 3, 25Sell$122KClaude MaraouiPresident & CEO↗
  • Feb 21, 25Sell$7KJoseph BeneschCFO↗
  • Aug 1, 24Sell$51KJoseph BeneschCFO↗
  • Jul 23, 24Sell$22KJoseph BeneschCFO↗
Stock compensation, tax and giftsshow the 28 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jul 1, 26Compensationamount n/aNeil Herskowitz↗
  • Jul 1, 26Compensationamount n/aJustin Adam Smith↗
  • Jul 1, 26Compensationamount n/aMiranda Jayne Toledano↗
  • Jun 25, 26Compensationamount n/aLINDSAY A ROSENWALD MD↗
  • Jun 25, 26Compensationamount n/aMichael Cooper Pearce↗
  • Jun 25, 26Compensationamount n/aNeil Herskowitz↗
  • Jun 25, 26Compensationamount n/aJustin Adam Smith↗
  • Jun 25, 26Compensationamount n/aMiranda Jayne Toledano↗
  • Apr 22, 26Compensationamount n/aClaude MaraouiPresident & CEO↗
  • Apr 22, 26Compensationamount n/aJoseph BeneschCFO↗
  • Apr 22, 26Compensationamount n/aRamsey AlloushChief Operating Officer↗
  • Aug 25, 25Compensation$81KClaude MaraouiPresident & CEO↗
  • Aug 25, 25Tax$81KClaude MaraouiPresident & CEO↗
  • Aug 5, 25Compensationamount n/aNeil Herskowitz↗
  • Aug 5, 25Compensationamount n/aMichael Cooper Pearce↗
  • Aug 5, 25Compensationamount n/aMiranda Jayne Toledano↗
  • Aug 5, 25Compensationamount n/aJustin Adam Smith↗
  • Aug 5, 25Compensationamount n/aLINDSAY A ROSENWALD MD↗
  • Jun 25, 25Compensationamount n/aNeil Herskowitz↗
  • Jun 25, 25Compensationamount n/aJustin Adam Smith↗
  • Jun 25, 25Compensationamount n/aMichael Cooper Pearce↗
  • Jun 25, 25Compensationamount n/aLINDSAY A ROSENWALD MD↗
  • Jun 25, 25Compensationamount n/aMiranda Jayne Toledano↗
  • Jun 17, 25Compensationamount n/aClaude MaraouiPresident & CEO↗
  • Jun 17, 25Compensationamount n/aJoseph BeneschCFO↗
  • Jun 17, 25Compensationamount n/aRamsey AlloushChief Operating Officer↗
  • Jul 19, 24Compensationamount n/aMichael Cooper Pearce↗
  • Jul 8, 24Compensationamount n/aLINDSAY A ROSENWALD MD↗

The full record holds 75 transactions and goes back to Nov 16, 21.

Its sector and its market

Journey Medical Corp among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Journey Medical Corp, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Journey Medical Corp in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
210 documents on file, from Aug 20, 2021 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.